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There has long been an appreciation that cerebral blood ¯ow is modulated to ensure adequate
cerebral oxygen delivery in the face of systemic hypoxaemia. There is increasing appreciation
of the modulatory role of hyperoxia in the cerebral circulation and a consideration of the
effects of such modulation on the maintenance of cerebral tissue oxygen concentration. These
newer ®ndings are particularly important in view of the fact that cerebrovascular and tissue
oxygen responses to hyperoxia may change in disease. Such alterations provide important
insights into pathophysiological mechanisms and may provide novel targets for therapy.
However, before the modulatory effects of hyperoxia can be used for diagnosis, to predict
prognosis or to direct therapy, a more detailed analysis and understanding of the physiological
concepts behind this modulation are required, as are the limitations of the measurement tools
used to de®ne the modulation. This overview summarizes the available information in this area
and suggests some avenues for further research.
Br J Anaesth 2003; 90: 774±86
Keywords: brain, blood ¯ow
Accepted for publication: November 20, 2002
One of the prime purposes of cerebral perfusion is to ensure
oxygen delivery to the brain. Cerebral blood ¯ow (CBF) is
coupled to cerebral oxygen metabolism to ensure appropri-
ate oxygen delivery both at baseline and dynamically in
response to cortical activity. There has long been an
appreciation that CBF is modulated to ensure adequate
cerebral oxygen delivery in the face of systemic
hypoxaemia.6 28 43 There is increasing appreciation of the
modulatory role of hyperoxia in the cerebral circulation and
a consideration of the effects of such modulation on the
maintenance of cerebral tissue oxygen levels.59 82 These
newer ®ndings are particularly important in view of the fact
that cerebrovascular and tissue oxygen responses to hypoxia
and hyperoxia may change in disease. Such alterations
provide important insight into pathophysiological mechan-
isms and may provide novel targets for therapy. However,
before the modulatory effects of hyperoxia can be used for
diagnosis, to predict prognosis or to direct therapy, a more
detailed analysis and understanding of the physiological
concepts behind the modulation is required, as are the
limitations of the measurement tools used to de®ne the
modulation. This review summarizes the available inform-
ation in this area and suggests some avenues for further
research.
Cerebral oxygen vasoreactivity
Cerebrovascular responses to hypoxia
Many factors in¯uence CBF, including oxygen, carbon
dioxide, metabolic demand and blood pressure. The clas-
sical response of CBF to changes in the arterial partial
pressure of oxygen (PaO2) is shown in Figure 1.
Over a normal physiological range of PaO2 (7±13.33 kPa),
there is little change in CBF. This is because CBF is related
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to the arterial content of oxygen (CaO2) rather than PaO2, and
the shape of the haemoglobin±oxygen dissociation curve
means that CaO2 is relatively constant over this PaO2 range.
Hypoxaemia, however, is a potent stimulus for arterial
dilatation, CBF beginning to increase at a PaO2 of ~7 kPa
(53 mm Hg); a decrease in the PaO2 from 6.67 to 3.33 kPa
(50 to 25 mm Hg) will produce cerebral vasodilatation
suf®cient to double the CBF. Despite the fact that it is a
fundamental and widely discussed response, data on the
precise threshold at which hypoxic vasodilatation occurs are
limited. The conventional thresholds quoted above arise
from experimental work done in anaesthetized dogs in the
1960s.54 More recent work in awake volunteers suggests
that hypoxic vasodilatation may be triggered at PaO2 levels
as high as 7.9 kPa (60 mm Hg).28 The mechanisms
responsible for this increase have been investigated exten-
sively; hydrogen ions, potassium ions, adenosine, nitric
oxide, arachidonic acid metabolites and ATP-sensitive K+
channels have all been implicated as mediators of the
process.77 Although clinical data from patients with chronic
anaemia appear to relate CBF to CaO2 rather than PaO2,
6 the
situation may be different with acute hypoxaemic chal-
lenges and, at least in rodents, the PaO2 appears to be more
important than the arterial oxygen content in regulating
cerebral vascular tone.77
Cerebrovascular responses to hyperoxia
The response of CBF to hyperoxia (PaO2 >15 kPa,
113 mm Hg), the cerebral oxygen vasoreactivity (COVR),
is less well de®ned. Kety and Schmidt originally described,
using a nitrous oxide washout technique,45 a reduction in
CBF of 13% and a moderate increase in cerebrovascular
resistance in young male volunteers inhaling 85±100%
oxygen.46 Subsequent human studies (Table 1), using a
variety of differing methods, have also shown CBF
reductions with hyperoxia, although the reported extent of
this change is variable.2 50 59 61 62 64 67 84 Omae and
colleagues64 assessed how supra-atmospheric pressures
in¯uenced CBF, as estimated by changes in middle cerebral
artery ¯ow velocity (MCAFV) in healthy volunteers.
Atmospheric pressure alone had no effect on MCAFV if
PaO2 was kept constant. Increases in PaO2 did lead to a
signi®cant reduction in MCAFV; however, there were no
further reductions in MCAFV when oxygen was increased
from 100% at 1 atmosphere of pressure to 100% oxygen at 2
atmospheres of pressure. This suggests that the ability of the
cerebral vasculature to constrict in response to increasing
partial pressures of oxygen is limited. Although hyperbaric
oxygen is thought to increase CBF in head-injured patients,
when the CBF is measured before and after the period of
hyperbaric oxygen; however, the acute response of CBF to
hyperbaric oxygen after head injury is not known.66
Some of the differences between the studies may result
from the varying methods used to measure CBF, each with its
own advantages and disadvantages, effects on physiology,
limits to the level of inspired oxygen achievable, and ability
to determine changes in regional and global CBF. A full
description of the different techniques is beyond the scope of
this review, but the various techniques are summarized in
Table 2; interested readers are directed to recent reviews on
the subject.7 43 56 74 Differences in respiratory physiology
mean that there will be inter-individual differences in PaO2
for a given inspired fraction of oxygen (FIO2). It would
therefore seem more logical to quantify changes in CBF in
terms of changes in PaO2 rather than FIO2. As carbon dioxide
usually has a much more dramatic effect on CBF than
oxygen, any measurement of COVR requires strict control
of carbon dioxide or, at least, correction of CBF to take into
account changes in carbon dioxide.
Fig 1 The in¯uence of arterial oxygen content (CaO2) and arterial partial pressure of oxygen (PaO2) on cerebral blood ¯ow (CBF). Below PaO2 ~7 kPa
(53 mm Hg), CBF increases. Within a normal physiological range of PaO2 there is little change in CBF (shaded box). Adapted with permission.
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Table 1 COVR studies
Study Patients/subjects Method Results Comments
Kety and Schmidt,
194846
Six healthy males Nitrous oxide. Oxygen increased
from 21% to 85±100%
Signi®cant decrease of 13% in
mean cerebral blood ¯ow
Leahy et al.,
198050
12 preterm infants Based on measurement of
occipitofrontal circumference
during inspiration of 100%
oxygen
15% reduction in CBF Hyperventilation during hyper-
oxia was corrected for by adding
1±2% CO2 to inspired gas. The
method of CBF measurement is
only suitable for young infants
Nakajima et al.,
198361
49 healthy volunteers. 38
asymptomatic volunteers with
risk factors for cerebral arterio-
sclerosis. 25 patients with
vertebrobasilar insuf®ciency.
37 patients with unilateral
hemispheric infarctions
133Xe inhalation followed by
clearance. Oxygen increased
from 21% to 100%
Mean reduction in CBF of
10.8%. Reduction of 16.2% in
normal subjects younger than
50 yr with symmetrical hemi-
spheric reductions. Lower CBF
reductions in patients with risk
factors, vertebrobasilar insuf®-
ciency and hemispheric infarction.
In acute infarction there was
paradoxical change in CBF, with
¯ow increasing rather than
decreasing in the infarcted
hemisphere
Only grey matter ¯ow was
assessed. There were signi®cant
reductions in E¢CO2 during
hyperoxia but this was not
enough to account for the
changes in CBF
Amano et al.,
19832
84 healthy volunteers. 11
patients with Alzheimer's type
dementia. Eight patients with
MID
133Xe inhalation followed by
clearance. Oxygen increased
from 21% to 100%
Progressive decrease in COVR
with advancing age. No
signi®cant difference in COVR
between patients with
Alzheimer's dementia and age-
matched controls. Patients with
MID showed reduced COVR;
COVR was asymmetrical
between hemispheres and hetero-
geneous within hemispheres
Only grey matter ¯ow was
assessed. Signi®cant reduction in
E¢CO2 during hyperoxia, but not
enough to account for the
changes in CBF.
Niijima, 198862 15 full-term infants. 17
premature infants
Anterior cerebral artery blood
velocity using Doppler. Oxygen
increased to produce a 3-fold
increase in arterial PO2
Reduced vasoreactivity in
premature infants compared with
full-term infants. In premature
infants velocities remained de-
creased, on return to normoxia,
during the 10 min observation
period. Velocities rapidly returned
to normal in full-term infants
Signi®cant falls in CO2 during
hyperoxia in the full-term infants,
which contributed to most of the
reduction in ¯ow velocity. This
was not the case for the prema-
ture infants
Rostrup et al.,
199567
Six healthy volunteers Magnetic resonance phase-
contrast angiography. Oxygen
increased from 21% to 50%
and 100%
27% reduction in CBF during
inhalation of 100% oxygen, no
¯ow changes during moderate
changes in FIO2
Magnetic resonance phase-con-
trast angiography quanti®es ¯ow
in the major cerebral arteries but
gives no information about regio-
nal changes. No signi®cant
changes in CO2
Omae et al.,
199862
Eight healthy volunteers MCAFV using transcranial
Doppler. Oxygen increased
from 21% to 100%
20% reduction in velocities Only MCAFV was assessed. In a
further part of the study, high
atmospheric pressure per se (PO2
kept constant) did not in¯uence
CBF in humans; CO2 stability
was good
Menzel et al.,
199959
Six patients with severe head
injury
Xe-CT scan at 35% oxygen
and 60% oxygen
Average global decrease in CBF
of ~9%. Extent of vasoreactivity
response depended on baseline
regional CBF
Time of the study in relation to
injury is not recorded. 30% Xe
was administered by inhalation; it
was therefore impossible to give
100% oxygen
Watson et al.,
200084
12 healthy volunteers Magnetic resonance phase-
contrast angiography and 100%
oxygen
Mean decrease in CBF of >20%,
greater in younger than in older
subjects. Decrease in CBF was
maintained during hyperoxia
and returned to normal, after
discontinuation of hyperoxia,
over ~6 min
There were signi®cant reductions
in measured E¢CO2. This may be
methodological and does not
account fully for the changes
found in CBF
CBF=cerebral blood ¯ow, COVR=cerebral oxygen vasoreactivity, CT=x-ray computed tomography, CTOR=cerebral tissue oxygen reactivity,
E¢CO2=end-tidal carbon dioxide, FIO2=inspired fraction of oxygen, FV=¯ow velocity, GOS=Glasgow Outcome Score, MCA=middle cerebral artery,
MCAFV=middle cerebral artery ¯ow velocity, MID=multi-infarct dementia, MRI=magnetic resonance imaging, N2O=nitrous oxide, PO2=partial
pressure of oxygen, 99mTc HMPOA=technetium 99m hexamethylpropyleneamineoxime, Xe=xenon.
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While the physiological purpose of hypoxaemic vaso-
dilatation is clear (maintenance of cerebral oxygen
delivery), the reasons for hyperoxic vasoconstriction are
less obvious. One hypothesis suggests that COVR is a
mechanism by which the brain attempts to protect itself
against high partial pressures of oxygen, perhaps to limit the
production of oxygen free radicals. Pulmonary and central
nervous system oxygen toxicity are well described in both
animals and humans, and both are believed to result from
excess production of reactive oxygen species and disinhibi-
tion of the transcription factor nuclear factor-kB (nuclear
factor-kB has important proin¯ammatory activity).9±11 13
Central nervous system oxygen toxicity is a well-recognized
problem in divers when exposed to oxygen pressures
>160 kPa (1200 mm Hg), leading to convulsions and loss
of consciousness, usually without any warning symptoms. It
is interesting that hypercapnia lowers the threshold for
central nervous system oxygen toxicity, probably because of
vasodilatation and therefore increased exposure to oxygen.
In rats, the central nervous system toxicity may result
from nitric oxide-induced escape from oxygen-induced
vasoconstriction and thus exposure of tissues to excessive
oxygen.14
Cerebral vasoreactivity in clinical settings
Three studies have looked more speci®cally at the effects of
pathology on COVR (Table 1). Nakajima and colleagues61
showed that COVR is reduced in patients with risk factors
for cerebral arteriosclerosis, vertebrobasilar insuf®ciency
and hemispheric infarction. In fact, in acute infarction there
was a paradoxical change in CBF, ¯ow increasing rather
than decreasing in the infarcted hemisphere. Amano and
colleagues2 showed reductions in COVR with age, and
showed that COVR is reduced and more heterogeneous in
patients with multi-infarct dementia than in age-matched
controls. These studies suggest that there has been disrup-
tion of the normal ability of the cerebral vasculature to
constrict in the presence of high levels of arterial oxygen.
Both studies used an inhalation xenon 133 (133Xe) washout
technique for determining CBF, a technique that is most
Table 2 Measurement of cerebral blood ¯ow
Technique Method Comments
Kety±Schmidt45 Uses rate of uptake of N2O to measure global CBF Cumbersome and invasive. Requires jugular bulb and arterial
catheters. Overestimates low perfusion states. N2O is not a truly
inert tracer. The technique can be carried out using inert tracers
such as krypton 85 and argon 25. Global measurement
133Xe washout Classic method uses extracranial gamma sensors to measure
washout curve of radioactive Xe after intracarotid injection.
Summated curves show fast and slow washout components
(? grey and white matter). Modi®cations include i.v. and
inhalational administration
Predominantly a measure of cortical blood ¯ow. Limited spatial
resolution. Recirculation and contamination by extracranial tissues
may affect results. Regional CBF reductions on one side may be
missed because of activity sensed in deeper or contralateral tissues.
Regional measurement
Xe-CT Stable Xe is radiodense and leads to enhancement of tissue
on standard CT scans. Cerebral perfusion can be calculated
from the time course of the build up of radiodensity
Signal-to-noise ratio can be high. Even low concentrations of Xe
(30%) may in¯uence CBF. Regional measurement
Doppler ultrasonography Measures FV in the major cerebral vessels, most commonly
the middle cerebral artery
Non-invasive. FV is an indirect measure of CBF. Use of FV to
assess changes in CBF relies on stability of both the angle of
insonation and the diameter of the insonated vessel. Regional
measurement
Phase-contrast magnetic
resonance angiography
Directional magnetic gradients are used to induce velocity-
dependent phase shifts in the MR signal from blood.
Knowledge of the cross-section of the vessel and calculated
¯ow velocity from this technique allows estimation of large-
vessel blood ¯ow
Measure of CBF but not perfusion. Only a measure of ¯ow in large
vessels (e.g. carotids), therefore poor spatial resolution
MRI Dynamic tracking of a bolus of a paramagnetic contrast
agent or arterial spin labelling
Quanti®cation is dif®cult
Positron emission
tomography
Positrons collide with electrons, resulting in destruction of
both and emission of two photons travelling in opposite
directions. A large number of detector pairs are used to
construct regional radioactivity. 15O-labelled water (H2
15O),
given as a bolus or using a steady-state technique, can be
used to quantify regional cerebral perfusion
15O has a short half-life and therefore repeated measurements are
possible. Coregistering with conventional CT or MRI images can
enhance the spatial resolution. Expensive and technically
demanding equipment. Arterial blood sampling required.
Single photon emission
computed tomography
(SPECT)
A gamma emitter, 99mTc HMPOA, is most commonly used.
Injected i.v. and distributed similarly to CBF. Rotating or
multidetector gamma camera used
Radiotracers have a long half-life that makes repeated measure-
ments dif®cult. Quantitative measurements of CBF have not been
very successful
Thermal diffusion A probe is inserted into the brain through a burr hole. Local
cortical blood ¯ow is calculated from the temperature
difference between two plates or from the tissue's ability to
dissipate heat
Invasive. Continuous. Only local, cortical blood ¯ow measured
FV=¯ow velocity, MR=magnetic resonance. For other abbreviations see footnote to Table 1.
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suited to measurement of cortical blood ¯ow and provides
little information about the white matter compartment.56
The use of several regional detectors placed over each
cerebral hemisphere gives a certain amount of information
on regional perfusion, although precise anatomical correl-
ations, and comparisons of the same region from one study
to another, are only semiquantitative. Menzel and col-
leagues59 used stable xenon computed tomography (CT) to
determine COVR, which makes use of the fact that stable
xenon is radiodense, and therefore CBF can be calculated
from the time course of tissue build-up of radiodensity.
They demonstrated a mean reduction in CBF of approxim-
ately 9%, with an increase in inspired oxygen from 35 to
60%, in six patients with severe traumatic brain injury. The
same group also assessed the response of CBF to hyperoxia
in an undamaged region of interest in the right frontal lobe,
and found an average reduction in CBF of 19.3%. Both
globally and in the region of interest, the extent of the
COVR was found to depend on the level of the baseline
regional CBF (Fig. 2). It is dif®cult to draw ®rm inferences
from Menzel's work as only six patients were studied, one
of whom had negligible CBF, but it does serve to
demonstrate the paucity of human data regarding traumatic
brain injury and COVR.
COVR has not been compared with other measures of
cerebral vascular reactivity, such as carbon dioxide
reactivity (changes in CBF in response to changes in
PaCO2) and pressure autoregulation, both of which are
known to be prognostic indicators after traumatic brain
injury.12 53 63 70 73 Therefore, it is not known whether
COVR is a measure of vascular reactivity per se (irrespec-
tive of the stimulus) or whether the cerebrovascular
response to oxygen is important in itself. Such comparisons
probably need to be preceded by a better understanding of
the physiology and a ®rmer methodological base.
Cerebral tissue oxygen partial pressures
Physiological premises
Measurement techniques
Several different types of tissue gas analysis probes are
available which are capable of measuring the partial
pressure of oxygen (PtO2) within a tissue of interest. The
volume of tissue sampled by these sensors is probably only
in the order of a few cubic millilitres.30 Although there is
some uncertainty over the exact characteristics of the partial
pressures that tissue sensors measure, for example whether
recordings are representative of intracellular or extracellular
gas pressures, and the in¯uence of sensor position in relation
to capillaries and arterioles, PtO2 is most probably a measure
of extracellular oxygen tension and thus re¯ects the balance
between oxygen supply and tissue demand. In metabolically
active tissue, an oxygen concentration gradient exists from
the arterial to the venous ends of a capillary as a result of
oxygen extraction. Normally it is assumed that there is a
minimal oxygen gradient between the extracellular space
and the end-capillary compartment, and thus that PtO2
re¯ects end-capillary oxygen tension. This may not be the
case after a severe head injury, when large end-capillary±-
tissue oxygen gradients occur, probably re¯ecting endovas-
cular oedema or microscopic arteriovenous shunts.27
Cerebral tissue oxygen partial pressures (PbO2) can be
measured using one of the two commercially available
sensors. The Licox system (GMS, Kiel-Mielkendorf,
Germany) consists of a sensor that includes a polarographic
Clark-type electrode, and a thermocouple for temperature
measurement. The electrode consumes tiny quantities of the
available tissue oxygen in an electrochemical reaction that
produces an electrical signal that is proportional to PbO2.
The NeurotrendÔ system (Codman, Raynam, MA, USA) is
made up of four different sensors (temperature, PbO2, PbCO2
Fig 2 Non-linear curve-®tting regression model between cerebral blood ¯ow (CBF) on 35% inspired oxygen (FIO2) and the percentage decrease in
CBF on 60% oxygen in a sequential double CBF study in six patients with severe traumatic brain injury. (A) CBF changes in a region of interest in
the right frontal lobe that appeared to be normal on CT scan. (B) Global CBF changes. Adapted with permission.58
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and pH) staggered over approximately 2 cm. The oxygen
sensor consists of a ®bre in which the holes are ®lled with
silicone rubber that contains entrapped ruthenium-based
dye. Blue light at 450±470 nm is passed down the ®bre and
is absorbed by the dye. The dye emits a proportion of the
energy it has absorbed as light of wavelength 620 nm.
However, in the presence of oxygen, the amount of this
¯uorescent light is reduced (so-called oxygen quenching).
The amount of quenching is proportional to the concentra-
tion of oxygen and thus, if the amount of ¯uorescent light is
measured, an estimate of PbO2 can be made. Both sensors
are approximately 0.5 mm in diameter but the oxygen-
sensing areas are of different lengths; both can be implanted
directly into brain tissue. The accuracies of the two sensors
are quoted at between 0.1 and 0.5 kPa (1±3.5 mm Hg), but
their accuracy declines when oxygen levels are supra-
physiological. The two sensors have never been compared
in a clinical situation. Before the Neurotrend sensor was
developed, a Paratrend sensor (Codman) was used in some
studies;58 59 early models of the Paratrend used a modi®ed
Clark electrode to measure oxygen partial pressure, but
more recently oxygen-quenching technology has been
introduced. The Clark electrode Paratrend has been com-
pared in vivo with the Licox, with various reports on the
comparability between the two sensors.68 79 The Paratrend
sensor is designed for arterial blood gas monitoring. It is
calibrated to work at higher oxygen tensions and therefore
may be more accurate in the measurement of supranormal
oxygen levels.
Several other monitoring tools and imaging techniques
are available to assess cerebral oxygenation, including
jugular bulb oximetry, microdialysis parameters, near
infrared spectroscopy and positron emission tomography
with 15O; detailed descriptions of these techniques are
beyond the scope of this review. Interested readers are
directed to recent reviews on the subject.29 41
Normal values and modulators
Few data exist on normal values of PbO2 in humans.
82 In cats
and dogs, normal values have been reported at 3.7
(SD 0.9) kPa [28 (7) mm Hg].52 Values of 4.3±4.7 kPa
(32±36 mm Hg) have been reported in normal tissue in three
patients undergoing brain tumour surgery,4 and values of
3.4±13.7 kPa (25±104 mm Hg) were reported in seven
patients having elective clipping of intracranial aneur-
ysms.15 The variability in these ®gures may be explained in
part by variations in the factors determining brain tissue
oxygen, which are outlined below.
Cerebral blood ¯ow. There is con¯icting evidence as
regards the relationship between PbO2 and CBF. Menzel
and colleagues59 and Doppenberg and colleagues16 have
used a single stable xenon-CT scan to measure CBF in a
region of interest around a Paratrend probe and have found
reasonable correlations with PbO2. However, Gupta and
colleagues27 did not ®nd a signi®cant correlation between
CBF and PbO2, using a Neurotrend sensor to determine PbO2
and H2
15O positron emission tomography imaging to
determine CBF. All of these studies were in brain-injured
patients.
Cerebral perfusion pressure. After traumatic brain injury,
episodes of reductions in cerebral perfusion pressure (CPP)
undoubtedly contribute to reductions in PbO2, various
thresholds for CPP having been reported.1 3 47 49 Kiening
and colleagues49 were able to show a third-order regression
correlation between PbO2 and CPP when a Licox sensor was
inserted into non-injured frontal tissue.
PaCO2 and PaO2. In most head-injured patients, hyper-
ventilation results in a decrease in PbO2 when the sensor is
placed in an uninjured part of the brain,26 37 although
increases are more commonly seen when the sensor is in an
area of pathology.26 Various studies have shown that
episodes of hypoxaemia may contribute to reductions in
PbO2.
1 49 82 The changes in PbO2 in response to hyperoxia
are discussed below (see Cerebral tissue oxygen reactivity).
Ischaemia. Imbalances between metabolic demand and
supply will lead to increases in oxygen extraction fraction
and thus to reductions in end-capillary oxygen tension.
Tissue oxygen levels should therefore re¯ect changes in
oxygen supply±demand relationships. Although some cor-
relations have been found between PbO2 and other indicators
of ischaemia, such as jugular venous oxygen saturation
(SjO2)
23 26 37 49 and regional lactate levels,78 a poor
correlation was found between PbO2 and end-capillary
oxygen tension, as calculated from 15O positron emission
tomography data.27 Poor correlations are not necessarily
surprising, as differences in the mechanisms of ischaemia
and the ischaemic burden will in¯uence different monitor-
ing modalities in different ways, as will the compartment
from which the measurement is made. Ischaemic thresholds
for PbO2 have been variably described using a number of
different approaches, such as outcome analysis after head
injury,5 16 17 47 59 79 81 85 relating PbO2 to recognized
threshold limits for CBF,17 59 relating PbO2 to SjO2 limits,
49
assessing PbO2 in patients with a compromised cerebral
circulation,31 and assessing thresholds for infarction during
cerebral aneurysm clipping.44 The threshold for ischaemia
that is most commonly used is approximately 1.3 kPa
(10 mm Hg).
Pharmacological and pathological modulation of CMRO2.
If ¯ow±metabolism coupling is intact, changes in the
cerebral metabolic rate of oxygen (CMRO2) should not
result in changes in PbO2. However, normal coupling of
CBF is only retained in 45% of comatose head-injured
patients,63 and pharmacological manipulation of CMRO2
may also disrupt normal coupling. Two studies have
suggested that etomidate can lead to reductions in PbO2,
sometimes to levels considered ischaemic;19 32 this is
Cerebral oxygen vasoreactivity and cerebral tissue oxygen reactivity
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probably a result of a reduction in oxygen supply attribut-
able to vasoconstriction, which is over and above the
reduction in metabolic oxygen requirements. Des¯urane has
the opposite effect, with increases in PbO2 as inhaled
des¯urane increases from 3% to 9%, probably as a result of
vasodilatation and hyperaemia. PbO2 falls with a reduction
in temperature, the fall becoming signi®cant at a brain
temperature below 35°C.25 This reduction in PbO2 is
associated with increases in SjO2 and therefore may repre-
sent a change in oxygen off-loading at the capillary level as
the oxygen dissociation curve shifts to the left.
Mitochondrial dysfunction will result in impaired ability
to utilize oxygen and a low CMRO2, and could arguably
result in vasodilatation; consequently PbO2 will be raised.
This constellation of ®ndings would seem plausible in
mitochondrial dysfunction, but has not been con®rmed by
robust experimental data in humans or experimental models.
Cerebral tissue oxygen reactivity
The expected changes in PbO2 that occur with changes in
PaO2 [cerebral tissue oxygen reactivity (CTOR)] are not
immediately intuitive. If brain tissue oxygen were depen-
dent on arterial oxygen content, then, because of the shape
of the oxygen dissociation curve, one would expect to see
little change in PbO2 during normoxia and hyperoxia. If
brain tissue oxygen were dependent on PaO2, one would
expect changes in PaO2 to be exactly re¯ected by changes in
PbO2. In practice, changes in PbO2 with changes in PaO2 do
not ®t either of these models. The experimental evidence
suggests that PbO2 increases with an increase in PaO2, but the
increase is damped (Fig. 3).
The term CTOR describes the changes in brain tissue
oxygen that occur with changes in arterial oxygenation
during hyperoxia. Various ethical and methodological
problems mean that measurement of a normal CTOR is
much more dif®cult than measurement of a normal COVR
(Table 3).
Quanti®cation
Van Santbrink and colleagues described the formula that is
the most widely used for measuring CTOR:82
CTOR=%DPbO2/DPaO2 (mm Hg)
One of the problems with the van Santbrink method is
that, for the same change in PaO2, a small, and probably
clinically insigni®cant, increase in PbO2 from 0.1 to 0.2 kPa
(0.8 to 1.6 mm Hg) would give the same CTOR as an
increase in PbO2 from 5 to 10 kPa (38 to 76 mm Hg).
Brain tissue oxygen normally has a linear relationship to
PaO2.
59 82 This relationship provides an alternative method
of determining CTOR, which avoids the problems inherent
in the van Santbrink method, CTOR being quanti®ed by the
gradient of the linear regression line. It is also essential to
make measurements during periods of stable physiology.
We have seen that that the process of equilibration between
arterial and brain oxygen may be extremely prolonged
(Fig. 4), which is probably a result of low perfusion.
Therefore, in order to determine an accurate CTOR,
suf®cient time must be given for PbO2 to reach a steady state.
Depending on the increase in PaO2 and the degree of
CTOR, both methods may rely on accurate measurements of
a high PbO2. This in itself may present a problem, as the
sensors that are available are only designed to measure
tissue oxygen accurately within a normal physiological
range. What both methods lack is the ability to describe the
clinical signi®cance of the improvement in PbO2. Various
retrospective studies have shown that periods of low brain
tissue oxygen correlate with an unfavourable neurological
outcome after severe traumatic brain injury.5 16 17 47 59 79±82 85
These data are consistent with studies showing that jugular
venous desaturations correlate with poor neurological
outcome;22 65 however, one large study of 119 patients
failed to show a signi®cant correlation between either PbO2
or SjO2 and outcome.
69 The threshold for unfavourable
outcome has been variably reported at between 0.8 and
Fig 3 Two hypothetical models of the relationships between brain tissue
oxygen (PbO2) and arterial oxygen content (CaO2) (solid line) and
between PbO2 and arterial partial pressure of oxygen (PaO2) (dashed line).
Hyperoxia (PaO2 >15 kPa) is indicated by the shaded area; within this
region the relationship does not ®t either model but falls between the two
(see text). Note the non-linear CaO2 axis. *There are very little data to
support either model under hypoxic conditions.
Table 3 Dif®culties in measurement of normal CTOR
Invasive brain tissue monitors required, e.g. Neurotrend
Measurements of tissue oxygen are very local and may not fully re¯ect global
heterogeneity
Probe insertion normally requires general anaesthesia, which may have
independent effects on tissue PO2
For ethical reasons, human subjects can only have brain tissue oxygen
monitoring if there is an ongoing pathological process
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2.6 kPa (6±20 mm Hg). It is not known if prospective
interventions aimed at achieving brain tissue oxygen levels
above these thresholds affect outcome, but it would be
useful if the calculation of CTOR indicated how changes in
PbO2 related to these potentially bene®cial thresholds.
Normal values
Using van Santbrink's formula, Menzel and colleagues57
described a normal CTOR, measured in the frontal lobe of
healthy anaesthetized piglets, as 0.21 (SD 0.12). CTOR has
been assessed in humans, in non-pathological brain tissue of
patients undergoing neurosurgery for brain tumours.21
Changes in PaO2 may not only affect PbO2 but also its
homogeneity in tissues. Eintrei and Lund21 used a multiwire
electrode to measure cortical tissue oxygen and showed that,
once the inspired oxygen reached 30%, brain tissue oxygen
became more scattered, heterogeneity increasing as the
inspired oxygen increased to 100%. Only three of the six
patients studied had an increase in mean brain tissue oxygen
when on oxygen 100% compared with normoxia. The same
group also studied the effects of hyperoxia on pig cerebral
cortex,21 where a similar increase in tissue oxygen hetero-
geneity was seen. All six pigs showed an increase in mean
tissue oxygen with hyperoxia but the reactivity varied
widely. Regional CBF was estimated in the pigs using a
washout curve of locally applied 133Xe. Although, when
compared with levels at an inspired oxygen fraction of 0.21,
CBF fell by an average of 40% at an inspired oxygen
fraction of 1.0, the extent of the reduction in CBF did not
correlate with the changes in brain tissue oxygen.
Pathological values
Four studies have investigated oxygen reactivity in humans
with cerebral pathology (Table 4).48 55 59 82 Both van
Santbrink and colleagues82 and Menzel and colleagues59
found a signi®cant correlation between high oxygen
reactivity and poor outcome (Glasgow Outcome Score 1,
2 or 3) after traumatic brain injury, the differences in
reactivity being most signi®cant on day 1. Neither study was
powered to ®nd a difference; this was an incidental
statistical ®nding. Van Santbrink and colleagues82 also
found that patients who had high brain oxygen levels had
signi®cantly higher oxygen reactivity, perhaps representing
deranged oxygen reactivity during the hyperaemic stage
after a head injury. The same group also looked at the
response of PbO2 to induced changes in PaCO2, and found
that the response on day 1 was signi®cantly lower than on
days 3 and 5 after traumatic brain injury, a result also found
by Carmona Suazo and colleagues.8 Impairments in brain
oxygen `carbon dioxide reactivity' are further evidence of
impaired vascular reactivity after traumatic brain injury,
which did not correlate with outcome. Meixensberger and
colleagues55 found higher CTORs in pathological brain
tissue than in normal brain tissue, whereas Kiening and
colleagues48 found a lower CTOR close to lesioned areas.
Other factors that have been shown to in¯uence CTOR
include hypercarbia and depth of iso¯urane anaesthesia,
both of which increase CTOR.33 34 It appears that non-
physiological vasodilatation (i.e. true hyperaemia) results in
an increase in CTOR.
Clinical signi®cance
Pathophysiological implications. A high CTOR could
represent one of two possible scenarios. It could either
represent vasomotor paralysis or it could be an appropriate
physiological response to ischaemia. Even normal or high
PbO2 values do not exclude tissue hypoxia. Mitochondrial
dysfunction is being increasingly recognized after severe
traumatic brain injury, and this could certainly result in high
tissue oxygen levels despite histotoxic hypoxia.83
Prognostic inferences. As mentioned previously, a signi®-
cant relationship between CTOR and outcome after
traumatic brain injury has been found in two studies.59 82
Therapeutic interventions. Only one study has assessed the
impact of hyperoxia on cerebral ischaemia after severe
TBI.58 It was found that increasing inspired oxygen from
35% to 100% for 6 h led to a 359 (SD 39)% increase in brain
tissue oxygen and a 40% decrease in brain lactate concen-
tration. The lactate/pyruvate ratio, which is more commonly
used as an indicator of the redox state of the brain,41 was not
assessed.
It is certainly possible to increase brain tissue oxygen
levels from an ischaemic level to a non-ischaemic level by
increasing the inspired fraction of oxygen, but there are no
randomized controlled trials assessing the impact of brain
tissue oxygen-targeted therapy after traumatic brain injury.
The effects of hyperoxia on cerebral metabolism and
ischaemia require further exploration using techniques
such as microdialysis, phosphorus and proton magnetic
resonance spectroscopy, and magnetic resonance diffusion-
weighted imaging.
Fig 4 Neurotrend printout showing pH, carbon dioxide and brain tissue
oxygen in response to changes in inspired oxygen (FIO2) in a head-
injured patient. A, FIO2 0.25 (start of monitoring); B, FIO2 0.5; C, FIO2
0.73; D, FIO2 0.98. All other physiological variables were stable during
the study.
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Mechanisms
The mechanisms that lie behind hyperoxia-induced changes
in tissue blood ¯ow and the regulation of tissue oxygen
partial pressures remain unclear. In human skeletal muscle,
hyperoxia causes an increase in the mean tissue oxygen
partial pressure, but with signi®cant heterogeneities, with
some regions of the tissue actually showing reduced oxygen
pressures compared with normoxia.51 This increase in tissue
oxygen heterogeneity with hyperoxia is also seen in the
brain in both pigs21 72 and man.21 The increase in
heterogeneity is speculated to be a result of redistribution
of blood ¯ow, with vasoconstriction in some areas and
shunting in others. Various mediators and mechanisms have
been suggested to play a role in COVR, including increased
effects of serotonin,75 76 nitric oxide synthase inhibition,71
inhibition of endothelial prostaglandin synthesis60 and
increased leukotriene production.39 40
Despite a number of advances in the last decade, the exact
site and mechanism of the oxygen sensor is yet to be fully
elucidated and, indeed, there may be more than one sensor.38
Many physiologically relevant genes are activated during
conditions of hypoxia, including those encoding erythro-
poietin, vascular endothelial growth factor, inducible nitric
oxide synthase and glycolytic enzymes. Remarkably, at the
transcriptional level, these diverse genes are all under the
control of a crucial transcription factor: hypoxia-inducible
factor 1 (HIF-1).24 HIF-1 is a heterodimeric protein complex
composed of two subunits: a constitutively expressed
b-subunit and an a-subunit, the expression and activity of
which are controlled by the intracellular oxygen concentra-
tion. During normoxia, HIF-1a is rapidly degraded by the
ubiquitin proteasome system, whereas exposure to hypoxic
conditions prevents its degradation.35 36 This oxygen-
dependent instability may provide a means by which gene
expression is controlled during changes in oxygen tension
(Fig. 5). We speculate that hyperoxia reduces the intra-
cellular HIF-1 concentration, thus reducing the activity of
important enzymes involved in glycolysis, such as phospho-
fructokinase and 6-phosphofructo-2-kinase/fructose-2,6-
bisphosphatase. A reduction in glycolysis would reduce
lactic acid production and intracellular buffering, and thus
modulate CBF. Indeed, we have seen that, in healthy
volunteers, hyperoxia modulates the haemodynamic re-
sponse to hyperventilation, and we speculate that this is a
result of reduced HIF-1 concentration and a decrease in
lactic acid production and intracellular buffering.42 The
effects of hyperoxia on cerebral glycolysis, metabolism and
ischaemia could be further explored using techniques such
as microdialysis, phosphorus or proton magnetic resonance
spectroscopy, and magnetic resonance diffusion-weighted
imaging. However, it is unlikely that it will be possible to
measure HIF-1 concentrations in vivo because of its
intracellular position, large size and instability. It should
certainly be possible to explore the effects of hyperoxia on
HIF-1 in the laboratory using cultured cell lines.
Conclusions
There is substantial evidence that CBF falls during periods
of hyperoxia, this fall having been variably reported
between 10 and 27% in healthy volunteers. There is some
evidence that COVR is disturbed by vascular disease and
traumatic brain injury.
Normal CTOR has not been well de®ned but it seems to
be in¯uenced by carbon dioxide, iso¯urane anaesthesia and
cerebral pathology, including traumatic brain injury.
Although CTOR has been shown in two studies to have
prognostic signi®cance after traumatic brain injury, further
work needs to be done in this ®eld. Temporal and spatial
pro®les of brain tissue oxygen reactivity need to be better
de®ned, as do the in¯uences of anaesthesia and sedation,
temperature and vasoactive agents. We have seen that brain
tissue oxygen does not always have a linear relationship
with arterial oxygen, and that the process of equilibration
Fig 5 Many physiologically relevant genes are activated during
conditions of hypoxia, including those encoding erythropoietin, vascular
endothelial growth factor, inducible nitric oxide synthase and glycolytic
enzymes. At the transcriptional level these diverse genes are all under the
control of a crucial transcription factor: hypoxia-inducible factor 1 (HIF-
1). HIF-1 is a heterodimeric protein complex composed of an a and b
subunit. During normoxia, HIF-1a is rapidly degraded by the ubiquitin
proteasome system, whereas exposure to hypoxic conditions prevents its
degradation. This oxygen-dependent instability may provide a means by
which gene expression is controlled during changes in oxygen tension.
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between arterial and brain oxygen may be extremely
prolonged (Fig. 4). For these reasons, de®nitions for
CTOR need to be more tightly de®ned.
If COVR and CTOR are to be used for diagnostic or
prognostic purposes, or to direct therapy, then the methodo-
logical issues surrounding their measurement must be taken
into account and future studies must be based on a ®rm
methodological foundation.
Whether poor COVR and supranormal CTOR describe
the same phenomenon is not yet known. How COVR and
CTOR integrate with more classic autoregulatory mechan-
isms requires investigation, as do the basic physiological
mechanisms that lie behind COVR and CTOR. Abnormal
pressure autoregulation and carbon dioxide reactivity are
known to correlate with poor outcome after traumatic brain
injury;12 53 63 70 73 further work is required to assess whether
COVR and CTOR offer complementary information.
Positron emission tomography, and magnetic resonance
imaging using hyperpolarized gases or per¯uorocarbons,
may allow further exploration of the relationships between
brain tissue oxygen, CBF, end-capillary oxygen tension,
COVR and CTOR.18 20 27
Further studies are required to determine whether
hyperoxia can provide clinical bene®ts in patients with
brain injury. At an appropriate stage, such studies should
include a randomized controlled trial assessing the use of
high fractions of inspired oxygen in the management of
severe traumatic brain injury.
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